about
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of HypertensionRationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA).Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study.Determinants of vascular phenotype in a large childhood population: the Avon Longitudinal Study of Parents and Children (ALSPAC).ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).Extended extraocular phenotype of PROM1 mutation in kindreds with known autosomal dominant macular dystrophy.Low rates of both lipid-lowering therapy use and achievement of low-density lipoprotein cholesterol targets in individuals at high-risk for cardiovascular disease across Europe.Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA studyStressing the obvious? Cell stress and cell stress proteins in cardiovascular disease.Levels of circulating endothelial cells and colony-forming units are influenced by age and dyslipidemia.Endothelial function and dysfunction: testing and clinical relevance.Childhood origins of arterial disease.HbA1c measurement and relationship to incident stroke.Socioeconomic status moderates the association between carotid intima-media thickness and cognition in midlife: evidence from the Whitehall II study.Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study.Prevalence and predictors of carotid wall triple line pattern in a general population sample.Predisposition to atherosclerosis by infections: role of endothelial dysfunction.Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.Improving diagnosis and treatment of women with angina pectoris and microvascular disease: the iPOWER study design and rationale.Higher systolic blood pressure with normal vascular function measurements in preterm-born children.Type 2 diabetes mellitus, metabolic syndrome, and mixed dyslipidemia: how similar, how different, and how to treat?The arterial pulse: vascular biology, vascular function testing, and therapies.Impact of aortic stenting on peripheral vascular function and daytime systolic blood pressure in adult coarctation.Circulating endothelial progenitor cells, vascular function, and cardiovascular riskSecondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and RehabA comparison of echocardiography and magnetic resonance imaging in cardiovascular screening of adults with Turner syndrome.Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD.Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B.Where are we heading with noninvasive clinical vascular physiology? Why and how should we assess endothelial function?Increased arterial stiffness in HIV-infected children: risk factors and antiretroviral therapy.Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis.Prognostic value of coronary vascular endothelial dysfunction.The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia.Low-dose sodium nitrite attenuates myocardial ischemia and vascular ischemia-reperfusion injury in human models.Endothelial function predicts progression of carotid intima-media thickness.Systemic vascular endothelial dysfunction in Peyronie's disease.Arterial stiffness and inflammatory response to psychophysiological stress.Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease.Achievement of lipoprotein goals among patients with metabolic syndrome at high cardiovascular risk across Europe. The EURIKA study.
P50
Q28301973-E7AF4BF0-6A19-4739-903B-F043EC421627Q33621905-CB5A7C5B-CA4E-487D-8692-E6C59773DBFBQ34020986-C8EE5E6D-742B-4BEE-B03C-AA3CD63F25ABQ34030500-D4CBD27F-3D33-432C-A738-C1E6FBBE229BQ34196167-5DCCBD9B-A0EC-475E-8F15-819F6740ECB3Q34212424-68C469A3-C15B-4EC0-B98E-F897D8F87178Q34514940-91936470-E6AD-4302-9709-CCAC19337569Q35097138-F3ECD323-A29B-45CF-8BEE-14065BACFBCBQ35187425-097426A9-CDD2-4CCB-AA69-0B15CB9E630DQ36671492-57353D3B-7C25-41CD-A470-25242032D8CEQ36705957-5C0B67C2-0030-4443-8E29-18EA29168EDBQ36758044-149D7EF0-3A40-47F2-A39F-17C7369A2BCAQ36948105-0C20682B-793A-4290-9164-A652BB1FE468Q37344069-BDD3838A-867D-4712-9C82-7E676103CA37Q37380473-F0461EA2-E872-43F1-9DC3-9AB4E9C9622BQ37612235-A4028266-048B-47D6-9F74-502B935DCCB7Q37633965-2FCC4AFB-B8D3-453E-9CAF-467D31D53D37Q37871635-211BAC2B-020E-4B1F-9549-75985D581129Q37965588-C994A752-748C-4E30-98AA-70E002349ECAQ38198197-E7615B15-A7F4-4937-9D42-F4FDCF9B366CQ38214891-38DD2DC4-CF89-4E95-BB2C-7FE347336D53Q38268764-29309D1C-42AB-48D3-9A06-89D5B5B8BCF7Q38369240-893594B3-19FF-404A-8CE1-207CFA5E69E8Q39331878-46F4036A-A326-4CC3-A512-0D5FEE133D7DQ39513285-F1358E55-24B6-41C2-A13B-756F82AEEB19Q39855352-79057B83-1512-4134-951D-A65F63D4CD33Q40463355-AEADFFA1-1270-4E39-B6D3-EAA2CAD33991Q41902756-565CC142-4AED-4FF0-89E0-81E30B21539EQ42165779-C8E146B1-6F77-4850-A2CF-08D3FCC6C710Q42870311-FB3E2C18-BAD8-4FF7-B1FD-93C1F0B0C7B6Q43208926-EAB1E7B5-5C75-4F73-B49E-B77B8BE539AFQ43754696-05389DBA-115A-4337-ADB5-8798BB315A95Q44090667-56B864E7-2B5B-4207-BCAA-92145219F010Q44182268-8549272F-C4B2-4A11-87D4-DCB250B9A360Q45902370-393ED83E-CD20-4E71-B980-A5763E41A26EQ46127803-6133D95F-E39C-481F-84EB-1A6873561768Q46475562-E4F0E891-352C-4CCD-8796-FD3EA88DF26EQ46721398-C8206DF3-FD93-4C7B-9234-78B11BFA8159Q47934879-83ED2B65-869B-40B8-A74D-E322D225A5D1Q48031635-9FBF2097-3BC0-4668-8AEF-D868FB63FAF6
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Julian Halcox
@ast
Julian Halcox
@en
Julian Halcox
@es
Julian Halcox
@nl
Julian Halcox
@sl
type
label
Julian Halcox
@ast
Julian Halcox
@en
Julian Halcox
@es
Julian Halcox
@nl
Julian Halcox
@sl
prefLabel
Julian Halcox
@ast
Julian Halcox
@en
Julian Halcox
@es
Julian Halcox
@nl
Julian Halcox
@sl
P106
P1153
6603008454
P21
P31
P496
0000-0001-6926-2947